In this context, we hypothesize that resveratrol could improve glycaemic control in T2DM, acting as an insulin sensitizer, and for that it must regulate GLUT4 and GLUT2 expressions, the molecular markers of glucose fluxes in muscle and liver. Here, SLC2A4 is linked to type 2 diabetes mellitus.